Nordic Bioproducts Group opens its first major production facility for advanced cellulosic materials
The Finnish startup has opened its state-of-the-art production facility in Lappeenranta, Finland, which is powered by the company’s proprietary AaltoCellTM Technology, and will produce at commercial-scale advanced cellulosic materials, including Microcrystalline Cellulose (MCC). The factory is expected to create 40 million euros in the first full operating year
Events
